Feng Y - Search Results

1

Biomineralized Two-Enzyme Nanoparticles Regulate Tumor Glycometabolism Inducing Tumor Cell Pyroptosis and Robust Antitumor Immunotherapy.

Zhang S, Zhang Y, Feng Y, Wu J, Hu Y, Lin L, Xu C, Chen J, Tang Z, Tian H, Chen X. Zhang S, et al. Among authors: feng y. Adv Mater. 2022 Dec;34(50):e2206851. doi: 10.1002/adma.202206851. Epub 2022 Nov 3. Adv Mater. 2022. PMID: 36193764

2

Tumor microenvironment as the "regulator" and "target" for gene therapy.

Wu J, Chen J, Feng Y, Tian H, Chen X. Wu J, et al. Among authors: feng y. J Gene Med. 2019 Jul;21(7):e3088. doi: 10.1002/jgm.3088. Epub 2019 May 21. J Gene Med. 2019. PMID: 30938916 Review.

3

An immune cocktail therapy to realize multiple boosting of the cancer-immunity cycle by combination of drug/gene delivery nanoparticles.

Wu J, Chen J, Feng Y, Zhang S, Lin L, Guo Z, Sun P, Xu C, Tian H, Chen X. Wu J, et al. Among authors: feng y. Sci Adv. 2020 Sep 30;6(40):eabc7828. doi: 10.1126/sciadv.abc7828. Print 2020 Sep. Sci Adv. 2020. PMID: 32998884 Free PMC article.

4

Combining mannose receptor mediated nanovaccines and gene regulated PD-L1 blockade for boosting cancer immunotherapy.

Chen J, Fang H, Hu Y, Wu J, Zhang S, Feng Y, Lin L, Tian H, Chen X. Chen J, et al. Among authors: feng y. Bioact Mater. 2021 Jun 4;7:167-180. doi: 10.1016/j.bioactmat.2021.05.036. eCollection 2022 Jan. Bioact Mater. 2021. PMID: 34466725 Free PMC article.

5

Photothermal-Chemotherapy Enhancing Tumor Immunotherapy by Multifunctional Metal-Organic Framework Based Drug Delivery System.

Ni W, Wu J, Fang H, Feng Y, Hu Y, Lin L, Chen J, Chen F, Tian H. Ni W, et al. Among authors: feng y. Nano Lett. 2021 Sep 22;21(18):7796-7805. doi: 10.1021/acs.nanolett.1c02782. Epub 2021 Sep 13. Nano Lett. 2021. PMID: 34516141

6

Metformin reprograms tumor microenvironment and boosts chemoimmunotherapy in colorectal cancer.

Ni W, Wu J, Feng Y, Hu Y, Liu H, Chen J, Chen F, Tian H. Ni W, et al. Among authors: feng y. Biomater Sci. 2022 Sep 27;10(19):5596-5607. doi: 10.1039/d2bm00988a. Biomater Sci. 2022. PMID: 35979933

7

Novel Cocktail Therapy Based on a Nanocarrier with an Efficient Transcytosis Property Reverses the Dynamically Deteriorating Tumor Microenvironment for Enhanced Immunotherapy.

Wu J, Guo Z, Ni W, Feng Y, Guo X, Meng M, Yuan Y, Lin L, Chen J, Tian H, Chen X. Wu J, et al. Among authors: feng y. Nano Lett. 2022 Sep 14;22(17):7220-7229. doi: 10.1021/acs.nanolett.2c02724. Epub 2022 Aug 22. Nano Lett. 2022. PMID: 35994713

8

Cationic polymer synergizing with a disulfide-containing enhancer achieved efficient nucleic acid and protein delivery.

Feng Y, Guo Z, Chen J, Zhang S, Wu J, Tian H, Chen X. Feng Y, et al. Biomater Sci. 2022 Oct 25;10(21):6230-6243. doi: 10.1039/d2bm01211a. Biomater Sci. 2022. PMID: 36107141

9

A generally minimalist strategy of constructing biomineralized high-efficiency personalized nanovaccine combined with immune checkpoint blockade for cancer immunotherapy.

Zhang S, Feng Y, Meng M, Li Z, Li H, Lin L, Xu C, Chen J, Hao K, Tang Z, Tian H, Chen X. Zhang S, et al. Among authors: feng y. Biomaterials. 2022 Oct;289:121794. doi: 10.1016/j.biomaterials.2022.121794. Epub 2022 Sep 7. Biomaterials. 2022. PMID: 36113330

10

CD47KO/CRT dual-bioengineered cell membrane-coated nanovaccine combined with anti-PD-L1 antibody for boosting tumor immunotherapy.

Liu S, Wu J, Feng Y, Guo X, Li T, Meng M, Chen J, Chen D, Tian H. Liu S, et al. Among authors: feng y. Bioact Mater. 2022 Oct 4;22:211-224. doi: 10.1016/j.bioactmat.2022.09.017. eCollection 2023 Apr. Bioact Mater. 2022. PMID: 36246666 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,929 results

Search Page

Filters